---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-045361"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:41:54.381228+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# QHSLab Q3 revenue up 62% to $544K, net income $49.8K, gross margin 67.1%

## Summary
- Revenue $544,285 (+62% YoY); gross margin 67.1% (up from 56.3%). Net income $49,765 vs ($82,000) loss in Q3 2023.
- ISP (digital health) segment revenue up 126% in Q3 to ~$162K; YTD growth 143% to ~$450K.
- Allergy kit sales +48% YoY to ~$220K. Surpassed 100,000 completed digital assessments.
- Debt reduction of >$100K from operating cash flow; R&D investment up to $187K YTD.
- Secured ~$300K grant for allergic rhinitis digital health research.

## SEC filing metadata
- accession: 0001493152-24-045361
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315224045361/0001493152-24-045361-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315224045361/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-045361
- JSON: https://secwatch.observer/filing/0001493152-24-045361.json
- Plain text: https://secwatch.observer/filing/0001493152-24-045361.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.